Major
Biology
Anticipated Graduation Year
2025
Access Type
Open Access
Abstract
End Stage Renal Disease (ESRD) is the final stage of chronic kidney disease, with only 10–15% kidney function remaining. Using 2023 data from Loyola University Medical Center, we evaluated 12 blood cellular indices as prognostic markers in ESRD versus healthy controls. Mann-Whitney U Test and Spearman Correlations showed significant differences (p<0.05) in most indices, excluding Platelet-to-Lymphocyte Ratio. Despite cohort variability, these findings highlight the potential of cellular indices as ESRD prognostic tools. This study lays the groundwork for future longitudinal analysis to track disease progression.
Faculty Mentors & Instructors
Dr. Jack Maggiore and Dr. Jawed Fareed
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
A Comparison of Blood Cellular Indices Between ESRD and a Healthy Ambulatory Population
End Stage Renal Disease (ESRD) is the final stage of chronic kidney disease, with only 10–15% kidney function remaining. Using 2023 data from Loyola University Medical Center, we evaluated 12 blood cellular indices as prognostic markers in ESRD versus healthy controls. Mann-Whitney U Test and Spearman Correlations showed significant differences (p<0.05) in most indices, excluding Platelet-to-Lymphocyte Ratio. Despite cohort variability, these findings highlight the potential of cellular indices as ESRD prognostic tools. This study lays the groundwork for future longitudinal analysis to track disease progression.
